VitroGro® is a defined, synthetic, animal product free platform technology with applications in research, industrial, pharmaceutical, clinical and medical markets.

This exclusive technology will deliver growth enhancing factors to cells, tissue and patients via a patented complex based on the protein vitronectin.

• GMP VitroGro® sold and distributed world wide exclusively through Invitrogen Corporation
• VitroGro® cell culture and protein products provide an animal-origin free substrate for feeder cell-free culture of cells, including stem cells for laboratory studies, as well as cell important industrially for protein production.

Medium-term

• Accelerated scarless wound healing:
  • Diabetic, venous & pressure ulcer treatments
  • Burns treatments
• Therapeutic cell growth products for pharmaceutical production of traditional and new technology vaccines

Long-term

• Bioactive wound dressing
• Skin ulcer treatments
• Tissue engineering applications for research and clinical fields
• Cosmeceuticals

Leading edge

• Anti-cancer vaccines
• Antagonist actions: atherosclerosis, tumor metastases